MarketCap
Facebook
X
Telegram
Ontrak EBITDA | OTRK
Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA), is an often used measure of a company's profitability. Financial analysts use EBITDA for a number of purposes including calculating simple valuations of a firm, estimating cash flows, and assessing debt servicing capability. The uses for EBITDA in financial analysis are numerous, but in practice should be more restrained. While EBITDA has some useful applications, it should be used with caution, as the problems with EBITDA are abundant and can lead to a number of misguided conclusions.[1]
EBITDA is an important indicator for investors and analysts because it allows them to evaluate a company's operating profit without considering the impact of financial expenses, taxes, or non-cash depreciation and amortization. It provides better comparability between companies in different industries or with different tax conditions.
EBITDA is often used to assess a company's ability to generate cash flow and repay debts. It can also serve as a measure of a company's operational efficiency, as it shows how profitable the core business is, regardless of external factors such as interest or taxes.
However, it is important to note that EBITDA is not an official financial statement measure and can be defined and calculated differently by companies. Therefore, investors and analysts should exercise caution when using EBITDA as an evaluation tool and combine it with other financial metrics and information to get a more complete picture of a company's financial condition.
Annual EBITDA Ontrak
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -17.2 M | -19.2 M | -41.5 M | -26.6 M | -13 M | -19.2 M | -13.3 M | -10.5 M | -6.43 M | -8.78 M | -5.57 M | -6.13 M | -8.62 M | -11.4 M | -12.6 M | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -5.57 M | -41.5 M | -14.7 M |
Quarterly EBITDA Ontrak
| 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -5.75 M | - | -5.01 M | -3.85 M | -4.07 M | - | -3.76 M | -4.33 M | -6.93 M | - | -10.3 M | -11.1 M | -12.4 M | - | -5.07 M | -1.35 M | -2.68 M | - | -2.81 M | -4 M | -5.98 M | - | -5.49 M | -4.87 M | -2.48 M | - | -3.99 M | -3.98 M | -4.16 M | - | -2.96 M | -2.57 M | -2.17 M | - | -2.05 M | -2.04 M | -2.42 M | - | -2.09 M | -2.45 M | -2.71 M | - | -1.52 M | -1.64 M | -1.4 M | - | -1.3 M | -1.47 M | -1.7 M | - | -2 M | -2.36 M | -2.72 M | - | -2.48 M | -2.99 M | -3.08 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -1.3 M | -12.4 M | -3.73 M |
References
- Brockman, C. M., & Russell, J. W. (2012). EBITDA: use it... or lose it?. International Journal of Business, Accounting and Finance, 6(2), 84-93.
EBITDA of other stocks in the Care facilities industry
| Issuer | EBITDA | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Aesthetic Medical International Holdings Group Limited
AIH
|
53.3 M | - | 10.96 % | $ 46.2 M |  China |
 |
Apollo Medical Holdings
AMEH
|
124 M | - | -2.11 % | $ 1.84 B |  USA |
 |
Мать и Дитя
MDMG
|
8.13 B | - | - | - |  Russia |
 |
Amedisys
AMED
|
121 M | - | 0.01 % | $ 3.3 B | USA |
 |
Avalon GloboCare Corp.
AVCO
|
-7.5 M | - | 26.45 % | $ 70.6 M | USA |
 |
Genesis Healthcare, Inc.
GEN
|
-162 M | - | - | $ 68.1 M | USA |
 |
Surgery Partners
SGRY
|
566 M | $ 15.73 | 3.35 % | $ 2 B | USA |
 |
Capital Senior Living Corporation
CSU
|
-235 M | - | -2.09 % | $ 216 M | USA |
|
Sanara MedTech
SMTI
|
11.3 M | $ 25.56 | 0.24 % | $ 220 M | USA |
 |
Five Star Senior Living Inc.
FVE
|
26.9 M | - | -0.32 % | $ 98.4 M | USA |
|
New Frontier Health Corporation
NFH
|
354 M | - | 3.54 % | $ 1.5 B | USA |
 |
Concord Medical Services Holdings Limited
CCM
|
-158 M | $ 4.3 | -0.69 % | $ 564 M | China |
 |
AMN Healthcare Services
AMN
|
101 M | $ 32.89 | -0.54 % | $ 1.27 B | USA |
 |
Hanger
HNGR
|
105 M | - | - | $ 732 M | USA |
 |
IMAC Holdings
IMAC
|
-5.48 M | - | -1.77 % | $ 25.4 M | USA |
 |
LHC Group
LHCG
|
132 M | - | - | $ 5.27 B | USA |
 |
American Shared Hospital Services
AMS
|
2.13 M | $ 1.46 | 2.1 % | $ 9.66 M | USA |
|
Novo Integrated Sciences
NVOS
|
-7.81 M | - | -13.87 % | $ 1.52 M | USA |
 |
Chemed Corporation
CHE
|
430 M | $ 511.13 | 1.86 % | $ 7.68 B | USA |
 |
MEDNAX
MD
|
231 M | $ 26.26 | 2.66 % | $ 2.21 B | USA |
 |
ModivCare
MODV
|
16.7 M | - | -25.23 % | $ 6.12 M | USA |
 |
Addus HomeCare Corporation
ADUS
|
155 M | $ 114.55 | 2.35 % | $ 2.07 B | USA |
 |
SunLink Health Systems
SSY
|
-1.04 M | - | 17.98 % | $ 7.81 M | USA |
 |
Oak Street Health
OSH
|
-97 M | - | 0.03 % | $ 9.53 B | USA |
 |
Regional Health Properties
RHE
|
3.73 M | - | - | $ 5.2 M | USA |
 |
Tivity Health
TVTY
|
154 M | - | 0.09 % | $ 1.6 B | USA |
 |
Elanco Animal Health Incorporated
ELAN
|
680 M | $ 24.91 | 0.52 % | $ 12.4 B | USA |
 |
Brookdale Senior Living
BKD
|
384 M | $ 15.15 | 4.48 % | $ 3.56 B | USA |
 |
Fresenius Medical Care AG & Co. KGaA
FMS
|
3.33 B | $ 24.59 | 0.61 % | $ 7.16 B |  Germany |
 |
The Pennant Group
PNTG
|
60.4 M | $ 41.16 | 3.39 % | $ 1.42 B | USA |
 |
Encompass Health Corporation
EHC
|
328 M | $ 112.89 | 1.65 % | $ 11.3 B | USA |
 |
Option Care Health
OPCH
|
405 M | $ 21.66 | 2.75 % | $ 3.51 B | USA |
 |
Healthcare Services Group
HCSG
|
16.8 M | $ 22.74 | 1.4 % | $ 1.65 B | USA |
 |
Community Health Systems
CYH
|
1.91 B | $ 2.73 | -1.8 % | $ 365 M | USA |
 |
DaVita
DVA
|
2.75 B | $ 235.44 | 0.5 % | $ 17.5 B | USA |
 |
COMPASS Pathways plc
CMPS
|
-179 M | $ 11.26 | -3.84 % | $ 1.05 B |  Britain |
 |
Select Medical Holdings Corporation
SEM
|
476 M | - | - | $ 2.02 B | USA |
 |
National HealthCare Corporation
NHC
|
173 M | $ 225.69 | 2.12 % | $ 3.49 B | USA |
 |
The Joint Corp.
JYNT
|
2.46 M | $ 8.35 | -0.12 % | $ 126 M | USA |
 |
Universal Health Services
UHS
|
2.61 B | $ 155.75 | 2.96 % | $ 9.9 B | USA |
 |
Phibro Animal Health Corporation
PAHC
|
156 M | $ 34.03 | -0.01 % | $ 1.38 B | USA |
 |
U.S. Physical Therapy
USPH
|
109 M | $ 74.58 | 2.02 % | $ 1.13 B | USA |
 |
HCA Healthcare
HCA
|
3.52 B | $ 382.19 | 1.51 % | $ 90.4 B | USA |
 |
Acadia Healthcare Company
ACHC
|
189 M | $ 34.51 | 1.47 % | $ 3.13 B | USA |
 |
The Ensign Group
ENSG
|
530 M | $ 172.99 | 3.27 % | $ 9.91 B | USA |
 |
Tenet Healthcare Corporation
THC
|
4.37 B | $ 233.2 | 17.17 % | $ 21 B | USA |